Financial Performance - For the three months ended June 30, 2022, the group's revenue was approximately HKD 44.0 million, a decrease of 16.5% from HKD 52.5 million in the same period of 2021[21]. - The group generated a net profit of approximately HKD 1.0 million for the three months ended June 30, 2022, down 80.4% from a net profit of HKD 5.1 million in the same period of 2021[21]. - Total comprehensive income for the period was HKD 1.0 million, significantly lower than HKD 5.1 million in the same period of 2021[24]. - Basic earnings per share for the three months ended June 30, 2022, was HKD 0.13, a decrease of 79.2% from HKD 0.64 in the same period of 2021[24]. - Profit for the same period was approximately HKD 1.0 million, down from HKD 5.1 million in the previous year, primarily due to the impact of COVID-19 and the temporary closure of medical beauty centers[74]. Revenue Breakdown - Revenue from treatment services for the three months ended June 30, 2022, was HKD 42,765,000, a decrease of 16.3% compared to HKD 51,389,000 for the same period in 2021[36]. - Total revenue for the three months ended June 30, 2022, was HKD 43,956,000, down from HKD 52,459,000 in the same period of 2021, representing a decline of 16.2%[36]. - The company's revenue for the three months ended June 30, 2022, was approximately HKD 44.0 million, a decrease of about HKD 8.5 million or 16.2% compared to the same period in 2021[57]. Dividends - The board of directors did not recommend the distribution of dividends for the three months ended June 30, 2022, consistent with no dividends declared in 2021[21]. - The company did not recommend any dividend for the three months ended June 30, 2022, consistent with the previous year[48]. - The company does not recommend the distribution of dividends for the three months ended June 30, 2022[75]. Expenses and Costs - The total employee costs for the three months ended June 30, 2022, were HKD 16,294,000, slightly down from HKD 16,651,000 in the same period of 2021, a decrease of 2.2%[38]. - The total marketing and promotional expenses for the three months ended June 30, 2022, were HKD 3,984,000, down from HKD 4,677,000 in the same period of 2021, a decrease of 14.8%[38]. - The cost of inventory and consumables for the three months was approximately HKD 7.1 million, down from HKD 7.8 million, consistent with the decline in revenue[62]. - Employee costs decreased to approximately HKD 16.3 million from HKD 16.7 million, attributed to the business being forced to close for a period due to COVID-19[66]. Other Income - The group reported other income of HKD 2.33 million for the three months ended June 30, 2022, compared to HKD 0.15 million in the same period of 2021[24]. - Other income for the three months ended June 30, 2022, was HKD 2,330,000, significantly up from HKD 147,000 in the same period of 2021[43]. - Other income increased to approximately HKD 2.3 million from HKD 0.1 million, mainly due to government subsidies received under the anti-epidemic fund[63]. Asset Management - The group's total assets as of June 30, 2022, were approximately HKD 64.1 million, reflecting a stable asset base[30]. Strategic Focus - The company continues to focus on expanding its skincare product offerings and enhancing service delivery in Hong Kong[30]. - The group is committed to ongoing research and development to innovate new products and improve existing services[30]. - The company aims to enhance its market penetration and profitability through strategic expansion of its medical beauty center network[56]. - The outlook for the medical beauty services industry remains optimistic despite uncertainties caused by COVID-19, with the company planning to leverage its strong customer base and reputation for steady business growth[60]. Operational Challenges - The company closely monitors the impact of COVID-19 on its financial condition and operational performance, indicating ongoing challenges in the market[53]. Shareholder Information - The major shareholders, Mr. Ye and Ms. Fu, each hold a 75% equity interest in the company through Equal Joy, which owns 600,000,000 shares[87][88]. - The company has a total of 600,000,000 shares held by Equal Joy, representing a significant portion of the equity structure[93]. - The board of directors consists of Mr. Ye and Ms. Fu as executive directors, along with independent non-executive directors[103]. Share Option Scheme - The company has not granted, exercised, or cancelled any options under the share option scheme since its adoption, and there are no outstanding options, warrants, or convertible securities as of June 30, 2022[97]. - The share option scheme aims to attract, retain, and reward eligible individuals for their contributions to the group, and it is valid for ten years unless terminated by shareholders[97]. - The company has not disclosed any other interests or holdings in shares or related securities by directors or major executives as of June 30, 2022[91][96]. - There were no known interests or holdings in competing businesses by directors or their associates during the three months ended June 30, 2022[101]. - The company has not established any arrangements for directors to benefit from acquiring shares or debt securities of the company or any other corporation[100].
亮晴控股(08603) - 2023 Q1 - 季度财报